Antiviral guanosine analogs as substrates for deoxyguanosine kinase: Implications for chemotherapy

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 3, 2001, Pages 739-742

  Herrstrom Sjoberg A ^a   Wang, L ^a   Eriksson, S ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYGUANOSINE; 3' FLUORO 2',3' DIDEOXYGUANOSINE; ACICLOVIR; ADENOSINE TRIPHOSPHATE; ANTIVIRUS AGENT; DEOXYGUANOSINE KINASE; GANCICLOVIR; GUANOSINE DERIVATIVE; LOBUCAVIR; PENCICLOVIR; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ANTIVIRAL ACTIVITY; ARTICLE; BRAIN; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG ACTIVITY; DRUG BINDING; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BINDING; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; GENE THERAPY; HEART; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; LIVER; PRIORITY JOURNAL; SIDE EFFECT; THYMUS;

ADENOSINE TRIPHOSPHATE; ANTIVIRAL AGENTS; DEOXYGUANINE NUCLEOTIDES; GUANOSINE; HUMANS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TISSUE DISTRIBUTION; URIDINE TRIPHOSPHATE;

EID: 0035119067     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.3.739-742.2001     Document Type: Article

References (35)

1. In vitro inhibition of hepatitis B virus replication by 2′,3′-dideoxyguanosine, 2′,3′-dideoxyinosine, and 3′-azido-2′,3′-dideoxythymidine in 2.2.15 (PR) cells
2. Mammalian deoxyribonucleoside kinases
3. Mitochondrial basis for immune deficiency. Evidence from purine nucleoside phosphorylase-deficient mice
4. Metabolic activation of the nucleoside analog 9-(2-hydroxy-l-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus
5. Characterization of a dCTP transport activity reconstituted from human mitochondria
6. In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir
7. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
8. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine
9. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: A selective inhibitor of herpes group virus replication
10. Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses
11. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine
12. Deoxyguanosine kinase. Distinct molecular forms in mitochondria and cytosol
13. Inhibition of cluck hepatitis B virus replication by 2′,3′-dideoxy-3′-fluoroguanosine in vitro and in vivo
14. Kinetic analysis of human deoxycytidine kinase with the true phosphate donor uridine triphosphate
15. Cloning and expression of human deoxyguanosine kinase cDNA
16. Mitochondrial and submitochondrial localization of human deoxyguanosine kinase
17. 2′,3′ -Dideoxy-3′-fluoroguanosine inhibits duck hepatitis B virus in vivo
18. Gone therapy for pediatric brain tumors
19. Kinetic mechanism and end-product regulation of deoxyguanosine kinase from beef liver mitochondria
20. Properties of a highly purified mitochondrial deoxyguanosine kinase
21. Cloning and characterization of mouse deoxyguanosine kinase. Evidence for a cytoplasmic isoform
22. Hepatic purine and pyrimidine metabolism: Implications for antiviral chemotherapy of viral hepatitis
23. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir
24. Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs
25. Interaction of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine with cytosol and mitochondrial deoxyguanosine kinases: Possible role in anti-cytomegalovirus activity
26. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS
27. Prolonged myocardial nucleotide depletion after brief ischemia in open-chest dog
28. Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein
29. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase
30. Famciclovir and penciclovir. The mode of action of famciclovir including its conversion to peciclovir
31. Substrate specificity of mitochondrial 2′-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine
32. Cloning and expression of human mitochondrial deoxyguanosine kinase cDNA
33. Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase
34. Enhanced cytotoxicity of nucleoside analogs by overexpression of mitochondrial deoxyguanosine kinase in cancer cell lines